Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018

SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14^th Legal Affairs Conference

25 April 2018

Key authorities, lawyers and industry leaders discussed today in London […]

Stakeholders To Gather In London To Plan Biosimilar Market’s Future

17 April 2018

Joint Declaration on Pharmaceuticals in the Environment

10 April 2018

We, the signatories of this declaration, recognise and understand the […]

Increasing access to cancer medicines: what role do biosimilar medicines play?

9 April 2018

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

30 March 2018

Statement in response to the EU Council ratifying the Brexit transition deal

23 March 2018

Today’s agreement on a transition period is welcome news for […]

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Supply chain commitment to tackling problem of medicine shortages

2 March 2018

El sistema español podría mejorar su coste-eficiencia con un plan nacional

27 February 2018